XClose

UCL Cancer Institute

Home
Menu

Network Members

The CITA Network contains a wealth of expertise in delivering Immunotherapies and Immunology research based at leading institutions London-wide. See core contacts at our network partners.

University College London: Cancer Institute

Henning Walczak

Professor of Cancer Biology
Lead applicant; contributes to cell death; inflammation; proteomics
h.walczak@ucl.ac.uk

Sergio Quezada

Group Leader: Immune Regulation and Tumour Immunotherapy Lab,
CRUK Senior Cancer Research Fellow
Co-leading scientist IMDC; GEnTILs Immunology and immunotherapy
s.quezada@ucl.ac.uk

Kerry Chester

Professor of Molecular Medicine, Head of the Recombinant Antibody Therapeutics Group
Provision of non-GMP-grade immune‐modulatory biotherapeutics
k.chester@ucl.ac.uk

Javier Herrero

Professorial Research Associate, Head of the Bill Lyons Informatics Centre
Bioinformatics
javier.herrero@ucl.ac.uk

Teresa Marafioti

Consultant Haematopathologist & Honorary Reader
Multi-colour IHC, tumour microenvironment and IHC assay development
t.marafioti@ucl.ac.uk

Karl Peggs

Reader in Haematology
Co-leading clinician scientist: ACT with GEnTILs and CARs
karl.peggs@ucl.ac.uk

Martin Pule

Senior Lecturer in Haematology
CAR-modified T cell therapies
martin.pule@ucl.ac.uk


University College London: Institute of Immunity & Transplantation

Emma Morris

Reader in Immunology and Immunotherapy
TCR-modified T cell therapies
e.morris@ucl.ac.uk

Hans Stauss

Head of Institute of Immunity &Transplantation, Professor of Tumour Immunology
TCR-modified T cell therapies
h.stauss@ucl.ac.uk

Ronjon Chakraverty

Professor of Haematology and Cellular Therapy ACT
Adaptive immune-regulation / Immune-activation
r.chakraverty@ucl.ac.uk


King's College London

Adrian Hayday

Kay Glendinning Professor of Immunobiology
Co-leading scientist IMDC; adaptiveimmune-regulation / Immune-activation
adrian.hayday@kcl.ac.uk

Tony Ng

Professor of Molecular Oncology
Tumour microenvironment/ Imaging
tony.ng@kcl.ac.uk


The Francis Crick Institute

Charles Swanton

Co-Director CRUK Lung Cancer Centre of Excellence
Co-leading clinician scientist: genomics; bioinformatics; GEnTILs
Charles.Swanton@crick.ac.uk

Julian Downward

Head of Signal Transduction Laboratory Response and resistance
iGEMMs
Julian.Downward@crick.ac.uk

Caetano Reis e Sousa

Head of Immuno-biology Laboratory
Adaptive immune-regulation / Immune-activation
Caetano@crick.ac.uk

Gitta Stockinger

Head of Division of Molecular Immunology
Adaptive immune-regulation / Immune-activation
Brigitta.Stockinger@crick.ac.uk


Royal Marsden Hospital

James Larkin

Medical Oncologist
Co-leading clinician scientist: clinical trials
James.Larkin@rmh.nhs.uk

Martin Gore

Medical Director of The Royal Marsden and Professor of Cancer Medicine
Clinical trials
Martin.Gore@rmh.nhs.uk


Institute of Cancer Research

Alan Melcher

Professor of Translational Immunotherapy
Oncolytic Viruses
Alan.Melcher@icr.ac.uk


Barts Cancer Institute

Frances Balkwill

Centre Lead, Centre for Cancer and Inflammation
Inflammation
f.balkwill@qmul.ac.uk

Kairbaan Hodivala-Dilke

Professor of Angiogenesis, Deputy Institute Director
Angiogenesis
k.hodivala-dilke@qmul.ac.uk